BCA
HALO icon

Bay Colony Advisors’s Halozyme HALO Stock Holding History

Bay Colony Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,450
Closed -$218K – 340
2022
Q2 		$218K Buy
+4,450
New +$192K 0.06% 300
2021
Q1 		– Sell
-5,400
Closed -$231K – 335
2020
Q4 		$231K Sell
5,400
-2,400
-31% -$86.3K 0.12% 244
2020
Q3 		$205K Buy
+7,800
New +$217K 0.13% 228

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bay Colony Advisors's HALO Position: Q3 2022 in Review

Bay Colony Advisors sold out of Halozyme (HALO) in Q3 2022, closing a stake of 4,450 shares — an estimated $218K sold.

Bay Colony Advisors first reported a position in HALO in Q3 2020 and held it in 3 quarters. The position peaked at $231K in Q4 2020. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

  • Bay Colony Advisors reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
  • Bay Colony Advisors sold 4,450 Halozyme shares in Q3 2022, an estimated $218K.
  • Bay Colony Advisors first reported a position in Halozyme in Q3 2020 and held it in 3 quarters.
  • Bay Colony Advisors's Halozyme position peaked at $231K in Q4 2020.
  • 357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Bay Colony Advisors's 13F filing for Q3 2022, filed 27 Oct 2022.